Why is Mercury Labs falling/rising?

As of 26-Sep, Mercury Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 832.00, reflecting a decrease of Rs 13.4 or 1.59%. The stock has been underperforming, having fallen consecutively for the last two days, with a total drop of 4.91% during this period. It has also touched an intraday low of Rs 806.25. The stock is trading below all its moving averages, indicating a bearish trend. Additionally, the company has reported a significant decline in profits, with a 24.6% decrease over the past year, contributing to its negative return of 17.28% in the same timeframe. Despite a low debt-to-equity ratio and a fair valuation, the stock is trading at a premium compared to its peers, which may deter investors.
In the broader market context, Mercury Laboratories has outperformed its sector by 0.75% today, but its one-week return of -1.07% contrasts with the Sensex, which has fallen by 2.66%. The pharmaceutical sector overall has declined by 2.35%, reflecting a challenging environment. The stock's liquidity appears to be decreasing, with a 65.03% drop in delivery volume compared to the five-day average, indicating reduced investor participation. This combination of poor long-term growth prospects, flat results, and declining investor interest suggests a challenging outlook for Mercury Laboratories in the current market.